Although it was thought Edward and Sophie would never recover, they proved the doubters wrong and after nearly 25 years of ...

On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $10.83 which represents a slight increase of $0.63 or 6.18% from the prior close of $10.2. The stock opened at $10.31 ...

Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...

William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...

A three-judge panel of the 3rd Circuit Court of Appeals this week reversed an order by a district judge in Pittsburgh affirming Pennsylvania laws that prohibit adults under the age of 21 from ...

For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...

William Blair initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating.Stay Ahead of the Market:Discover outperforming ...

Fintel reports that on January 15, 2025, William Blair initiated coverage of SoFi Technologies (NasdaqGS:SOFI) with a ...

Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...

SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...